1
Gail Eugene Smith, James T Matthews, Edwin D Kilbourne, Bert E Johansson, Bethanie E Wilkinson, Andrei I Voznesensky, Craig S Hackett, Franklin Volvovitz: Neuraminidase-supplemented compositions. Protein Sciences Corporation, William S Frommer, Thomas J Kowalski, Frommer Lawrence & Haug, November 26, 2002: US06485729 (11 worldwide citation)

An anti-influenza vaccine composition wherein the improvement is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially available anti-influenza vaccine. The composition can include and be administered with an adjuvant. The vaccine comp ...


2
Rabindra N Das, John M Lauffer, Voya R Markovich, James T Matthews: Method of making an internal capacitive substrate for use in a circuitized substrate and method of making said circuitized substrate. Endicott Interconnect Technologies, Hinman Howard & Kattell, Lawrence R Fraley, Mark Levy, June 10, 2008: US07384856 (8 worldwide citation)

A method of forming a capacitive substrate in which first and second conductors are formed opposite a dielectric, with one of these electrically coupled to a thru-hole connection. Each functions as an electrode for the resulting capacitor. The substrate is then adapted for being incorporated within ...


3
Gail Eugene Smith, James T Matthews, Edwin D Kilbourne, Bert E Johansson, Bethanie E Wilkinson, Andrie I Voznesensky, Craig S Hackett, Franklin Volvovitz: Methods of making neuraminidase-supplemented compositions. Protein Sciences Corporation, Frommer Lawrence & Haug, Thomas J Kowalski, Angela M Collison, October 4, 2005: US06951649 (4 worldwide citation)

The present invention relates to a method for formulating a vaccine composition which comprises an anti-influenza vaccine, wherein the improvement of the vaccine composition is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially avai ...


4
James T Matthews, Katerina Leftheris, Robert K Hamatake, John T Stevens, Mary L Haffey: Antiviral peptides. E R Squibb & Sons, Stephen B Davis, January 12, 1999: US05859187 (3 worldwide citation)

Inhibition of UL42 stimulation of herpesvirus DNA polymerase activity is exhibited by novel compounds of the formulas


5
Mary L Haffey, James T Matthews: Selective inhibition of DNA polymerase. E R Squibb & Sons, James M Bogden, June 9, 1992: US05120639 (1 worldwide citation)

Two peptides, P6 and P7, having the amino acid sequence APGDEPAPPY and AGATAEETRY have been used to obtain antibodies made against them, which antibodies specifically neutralize HSV-1 and HSV-2 DNA polymerase. The present invention also contemplates a method of screening for inhibitors of HSV-1 and ...


6

7
Gale Eugene Smith, James T Matthews, Edwin D Kilbourne, Bert E Johansson, Bethanie E Wilkinson, Andrei I Voznesensky, Craig S Hackett, Franklin Volvovitz: Neuraminidase-supplemented compositions. Frommer Lawrence & Haug, September 4, 2003: US20030165521-A1

An anti-influenza vaccine composition wherein the improvement is that the vaccine includes, as an additive, neuraminidase (NA). The base anti-influenza vaccine can be any commercially available anti-influenza vaccine. The composition can include and be administered with an adjuvant. The vaccine comp ...


8
Rabindra N Das, John M Lauffer, Voya R Markovich, James T Matthews: Method of making an internal capacitive substrate for use in a circuitized substrate and method of making said circuitized substrate. Endicott Interconnect Technologies, Lawrence R Fraley, Hinman Howard & Kattell, July 13, 2006: US20060154434-A1

A method of forming a capacitive substrate in which first and second conductors are formed opposite a dielectric, with one of these electrically coupled to a thru-hole connection. Each functions as an electrode for the resulting capacitor. The substrate is then adapted for being incorporated within ...


9


Click the thumbnails below to visualize the patent trend.